Previously, we have shown that EBI3 expression by tumoral cells is lower in follicular lymphomas (from 1 to 30% positive tumoral cells at the most) than in DLBCL [15], and remains lower (less than 30% positive tumoral cells) in established transformed follicular lymphomas (our unpublished data). This evidence concerns the gene EBI3 and diffuse large B-cell lymphoma.